Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Hamilton Biotechnology, widely known as Hanteng Biotech, is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the development of biologics. Founded in 2016 and based in Guangzhou, China, the company provides comprehensive services including mammalian cell line development, upstream and downstream process development, and analytical method development. Their proprietary H-Genius platform is designed for high-efficiency expression of complex proteins, including monoclonal antibodies and bispecifics. Hamilton Biotech operates multiple facilities that adhere to global GMP standards, supporting clients from early-stage research through to clinical and commercial manufacturing. The company has established a significant presence in the Chinese biopharma ecosystem with expanding international collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Hamilton Biotechnology.